References
- Bhatla, N., et al., 2018. Revised FIGO staging for carcinoma of the cervix uteri. International Journal of Gynecology & Obstetrics, 145, 129–135.
- Bizzarri, N., et al., 2021. PeritonealHPV‐DNA test in cervical cancer (PIONEER study): a proof of concept. International Journal of Cancer, 148 (5), 1197–1207.
- Bogani, G., et al., 2022. Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia. Vaccines, 10 (4), 579.
- Fritz, A., et al., 2000. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization. https://apps.who.int/iris/handle/10665/42344.
- Giannini, A., et al., 2022. Minimally Invasive Surgery for Cervical Cancer: Should We Look beyond Squamous Cell Carcinoma? Journal of Investigative Surgery : The Official Journal of the Academy of Surgical Research, 35 (7), 1602–1603.
- Hu, K., et al., 2018. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy. Radiation Oncology, 13 (1), 249.
- Kurman, R. J., et al., 2014. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: International Agency for Research on Cancer.
- Kwon, J., et al., 2018. The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04). Cancer Research and Treatment, 50 (3), 964–974.
- Liu, Q., et al., 2020. Development and validation of a SEER-based prognostic nomogram for cervical cancer patients below the age of 45 years. Bosnian Journal of Basic Medical Sciences, 21 (5), 620–631.
- Ni, X., et al., 2021. Development and validation of a novel nomogram to predict cancer-specific survival in patients with uterine cervical adenocarcinoma. Annals of Translational Medicine, 9 (4), 293–293.
- Ramirez, P. T., et al., 2018. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. The New England Journal of Medicine, 379 (20), 1895–1904.
- Siegel, R. L., et al., 2021. Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, 71 (1), 7–33.
- Stolnicu, S., et al., 2018. International Endocervical Adenocarcinoma Criteria and Classification (IECC). The American Journal of Surgical Pathology, 42 (2), 214–226.
- Sung, H., et al., 2021. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a Cancer Journal for Clinicians, 71 (3), 209–249.
- Valenti, G., et al., 2017. Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice? Updates in Surgery, 69 (4), 441–449.
- Wang, C., et al., 2018. A Prognostic Nomogram for Cervical Cancer after Surgery from SEER Database. Journal of Cancer, 9 (21), 3923–3928.
- Wang, Z., et al., 2021. A nomogram prediction model for lymph node metastasis in endometrial cancer patients. BMC Cancer, 21 (1), 748.
- WMA, 2013. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA, 310 (20), 2191–2194.
- Xie, S., et al., 2020. Characteristics and treatments of patients aged 65 years or over with cervical cancer. Clinical Interventions in Aging, 15, 841–851.
- Yi, J., et al., 2022. Development and validation of novel nomograms to predict the overall survival and cancer-specific survival of cervical cancer patients with lymph node metastasis. Frontiers in Oncology, 12, 857375.
- Zhou, J., et al., 2018. Postoperative clinicopathological factors affecting cervical adenocarcinoma. Medicine, 97 (2), e9323.
- Zhu, H., et al., 2022. The impact of minimally invasive surgery on treating patients with early cervical adenocarcinoma. Journal of Investigative Surgery, 35 (7), 1593–1601.